Mergers & AcquisitionsBy The Online Investor Staff, updated Thu., Aug. 6, 5:16 AM
|This Slide: #2 of 100|
Slide #2. R. & D. Biocogency Laboratories Inc. Ltd — Rafarma Pharmaceuticals, Inc.
R. & D. Biocogency Laboratories Inc. Ltd
Rafarma Pharmaceuticals, Inc. (RAFA)
Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has reached an agreement to be acquired by R. & D. Biocogency Laboratories Inc. Ltd ("Biocogency"). Under the agreed terms, Bio-cogency will acquire majority control of Rafarma Pharmaceuticals Inc. upon completion of Biocogency's transition to GAAP reporting standards and finalization of acquisition agreements.